Immuron Ltd (IMC) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.189x

Based on the latest financial reports, Immuron Ltd (IMC) has a cash flow conversion efficiency ratio of -0.189x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-2.48 Million ≈ $-1.75 Million USD) by net assets (AU$13.08 Million ≈ $9.25 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of Immuron Ltd to measure how many days the company can operate on defensive assets alone.

Immuron Ltd - Cash Flow Conversion Efficiency Trend (2001–2025)

This chart illustrates how Immuron Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Immuron Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Immuron Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Vivos Therapeutics Inc
NASDAQ:VVOS
4.743x
Alta Zinc Limited
F:8EE
-0.151x
Viji Finance Limited
NSE:VIJIFIN
0.017x
Evolva Holding SA
SW:EVE
-0.074x
FD Technologies Plc
LSE:FDP
0.086x
Tapaco Public Company Limited
BK:TAPAC
0.056x
JPMorgan Global Emerging Markets Investment Trust PLC
LSE:JEMI
0.010x
Agro Phos India Limited
NSE:AGROPHOS
0.113x

Annual Cash Flow Conversion Efficiency for Immuron Ltd (2001–2025)

The table below shows the annual cash flow conversion efficiency of Immuron Ltd from 2001 to 2025. For the full company profile with market capitalisation and key ratios, see IMC company net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$8.07 Million
≈ $5.71 Million
AU$-6.14 Million
≈ $-4.34 Million
-0.761x -64.39%
2024-06-30 AU$12.71 Million
≈ $8.99 Million
AU$-5.88 Million
≈ $-4.16 Million
-0.463x -264.71%
2023-06-30 AU$19.62 Million
≈ $13.88 Million
AU$-2.49 Million
≈ $-1.76 Million
-0.127x +6.13%
2022-06-30 AU$23.18 Million
≈ $16.40 Million
AU$-3.13 Million
≈ $-2.22 Million
-0.135x +14.30%
2021-06-30 AU$25.90 Million
≈ $18.32 Million
AU$-4.08 Million
≈ $-2.89 Million
-0.158x +71.88%
2020-06-30 AU$5.64 Million
≈ $3.99 Million
AU$-3.16 Million
≈ $-2.24 Million
-0.561x -129.19%
2019-06-30 AU$7.35 Million
≈ $5.20 Million
AU$-1.80 Million
≈ $-1.27 Million
-0.245x +41.08%
2018-06-30 AU$8.44 Million
≈ $5.97 Million
AU$-3.50 Million
≈ $-2.48 Million
-0.415x +61.17%
2017-06-30 AU$6.57 Million
≈ $4.65 Million
AU$-7.03 Million
≈ $-4.97 Million
-1.069x -2.42%
2016-06-30 AU$4.94 Million
≈ $3.50 Million
AU$-5.16 Million
≈ $-3.65 Million
-1.044x -66.26%
2015-06-30 AU$4.81 Million
≈ $3.40 Million
AU$-3.02 Million
≈ $-2.14 Million
-0.628x -60.80%
2014-06-30 AU$6.79 Million
≈ $4.80 Million
AU$-2.65 Million
≈ $-1.88 Million
-0.391x +97.23%
2013-06-30 AU$144.99K
≈ $102.59K
AU$-2.05 Million
≈ $-1.45 Million
-14.108x -1074.35%
2012-06-30 AU$2.05 Million
≈ $1.45 Million
AU$-2.46 Million
≈ $-1.74 Million
-1.201x -5.67%
2011-06-30 AU$1.73 Million
≈ $1.23 Million
AU$-1.97 Million
≈ $-1.39 Million
-1.137x -69.19%
2010-06-30 AU$3.36 Million
≈ $2.38 Million
AU$-2.26 Million
≈ $-1.60 Million
-0.672x -105.99%
2009-06-30 AU$-184.87K
≈ $-130.81K
AU$-2.07 Million
≈ $-1.47 Million
11.209x +699.89%
2008-06-30 AU$1.11 Million
≈ $785.58K
AU$-2.07 Million
≈ $-1.47 Million
-1.868x -23.80%
2007-06-30 AU$1.98 Million
≈ $1.40 Million
AU$-2.99 Million
≈ $-2.12 Million
-1.509x -181.71%
2006-06-30 AU$5.24 Million
≈ $3.71 Million
AU$-2.81 Million
≈ $-1.99 Million
-0.536x -112.46%
2005-06-30 AU$6.96 Million
≈ $4.93 Million
AU$-1.76 Million
≈ $-1.24 Million
-0.252x +16.78%
2004-06-30 AU$4.08 Million
≈ $2.89 Million
AU$-1.24 Million
≈ $-874.24K
-0.303x +0.21%
2002-06-30 AU$6.32 Million
≈ $4.47 Million
AU$-1.92 Million
≈ $-1.36 Million
-0.304x -36.77%
2001-06-30 AU$7.48 Million
≈ $5.29 Million
AU$-1.66 Million
≈ $-1.17 Million
-0.222x --

About Immuron Ltd

AU:IMC Australia Biotechnology
Market Cap
$6.93 Million
AU$9.80 Million AUD
Market Cap Rank
#27872 Global
#1440 in Australia
Share Price
AU$0.03
Change (1 day)
-9.09%
52-Week Range
AU$0.03 - AU$0.09
All Time High
AU$0.86
About

Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada. It operates through two segments, Research and Development; and Hyper-immune Products. The company offers Travelan, an over-the-counter medicine to reduce the risk of travelers' diarrhea and risk of minor gastrointestinal d… Read more